Utilizing Machine-Learning Capabilities
When Will Big Data Analytics Change Biopharmaceutical and Pharma Manufacturing?
Precision Medicine Research in the Million-Genome Era
Gaining the Most from Research with Multi-Omic Data in the Million-Genome Era
Top 10 M&A Deals of 2016
While 2016 Didn’t Reach the Heights Predicted, the Overall Value of Biopharma M&A Climbed
U.K. Bioindustry Plots Its Post-Brexit Course
Improving Manufacturing of Advanced Therapies Is One of Several Initiatives Being Put in Place
- 8405 Helgerman Ct
- Gaithersburg MD, 20877
- UNITED STATES
Trevigen Cell Assays (TCA), a division of Trevigen, Inc., was established in 2008 to conduct contract research work for the pharmaceutical, biotechnology, government and academic segments of the medical research market. TCA specializes in designing and conducting assays for lead compounds and genotoxic screening based on DNA damage and repair as well as cancer cell behavior.